Global Mesenchymal Stem Cells Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 89.25 Million |
 Market Size (Forecast Year) |
USD 132.81 Million |
 CAGR |
% |
| Major Markets Players |
|
>全球间充质干细胞市场，按类型（自体、同种异体）、产品类型（人类 MSC、小鼠 MSC、大鼠 MSC）、分离来源（骨髓、脐带血、外周血、输卵管、胎儿肝脏、肺、脂肪组织）、适应症（骨与软骨修复、心血管疾病、炎症与免疫疾病、肝脏疾病、癌症、移植物抗宿主病、其他）、应用（疾病建模、药物开发与发现、干细胞库、组织工程、毒理学研究、其他）、最终用户（诊所、医院、其他）划分——行业趋势与预测至 2030 年。
间充质干细胞市场分析和规模
由于老年人口增加、慢性病患病率上升、政府举措不断增加、对干细胞生物学的投资不断增加、治疗方案不断进步以及意识不断提高，间充质干细胞的使用增加是扩大全球间充质干细胞市场的因素。在 2023-2030 年的预测期内，不断增加的研发活动和不断增加的骨科手术将为全球间充质干细胞市场提供有利的机会。
Data Bridge Market Research 分析，全球间充质干细胞市场在 2022 年为 8925 万美元，预计到 2030 年将达到 1.3281 亿美元，预计在 2023-2030 年预测期内的复合年增长率为 5.2%。这表明市场价值。“医院”在全球间充质干细胞市场的终端用户细分市场中占据主导地位，因为那里的产品应用范围广泛。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。
间充质干细胞市场范围和细分
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021 (可定制为 2014-2020) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
类型（自体、同种异体）、产品类型（人类 MSC、小鼠 MSC、大鼠 MSC）、分离来源（骨髓、脐带血、外周血、输卵管、胎儿肝脏、肺、脂肪组织）、适应症（骨和软骨修复、心血管疾病、炎症和免疫疾病、肝脏疾病、癌症、移植物抗宿主病、其他）、应用（疾病建模、药物开发和发现、干细胞库、组织工程、毒理学研究、其他）、最终用户（诊所、医院、其他） |
|
覆盖国家 |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America. |
|
Market Players Covered |
Lonza (Switzerland),Thermo Fisher Scientific Inc. (U.S.), Bio-Techne (U.S.), ATCC (American Type Culture Collection) (U.S.),Merck KGaA (Germany), PromoCell GmbH (Germany), Genlantis, Inc. (U.S.), Celprogen Inc. (U.S.), Cell Applications, Inc. (U.S.), Cyagen Biosciences (U.S.), Axol Bioscience Ltd. (U.K.) |
|
Market Opportunities |
|
Market Definition
Mesenchymal stem cells are adult stem cells whose main function is to repair and replace damage tissue. They show high potential for tissue repair and are isolated from other tissues such as bone marrow, cord blood, peripheral blood, fallopian tube, fetal liver, lung, and adipose tissues. They are a renewable source for the substitution of cells and tissues to treat diseases.
Global Mesenchymal Stem Cells Market Dynamics
Drivers
- Increasing Prevalence of Chronic Diseases
The rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and orthopaedic disorders is a major driver of the MSCs market. MSCs hold promise for regenerative therapies to treat these conditions effectively.
Such global prevalence of disease and their increasing cases with most of the population in the majority of countries turns towards older age contribute to new research and development in musculoskeletal disease which is expected to drive the global mesenchymal stem cells market.
- Rising Number of Geriatric Population
Expanding geriatric population worldwide is predicted to favour the mesenchymal stem cells demand as this population is more prone to develop diseases. The number of persons above 65 years is projected to double in the coming years. The global aging population is more susceptible to age-related diseases and conditions, creating a greater demand for treatments that can address these health issues. MSC-based therapies hold promise in addressing age-related degenerative diseases, which can foster the demand for the mesenchymal stem cells across the globe.
- Increasing Clinical Trials and Research Initiatives
There has been a surge in clinical trials and research studies exploring the therapeutic potential of MSCs in various medical fields, including oncology, neurology, and autoimmune diseases. This research drives the demand for MSCs and related products.
Moreover, regenerative medicine, which focuses on repairing or replacing damaged tissues and organs, has gained significant attention. MSCs have emerged as a promising tool for regenerative therapies, driving demand for their isolation, expansion, and characterization which will further act as driver that will lead to the growth of the global mesenchymal stem cells market in the above mentioned projected timeframe.
Opportunity
- Increasing Technological Advancements
Advances in cell culture techniques, bioprocessing, and cell characterization methods have improved the scalability and efficiency of MSC production, making them more accessible for research and clinical applications owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.
Additionally, both public and private investments in stem cell research and regenerative medicine have risen significantly. Funding supports research and development activities related to MSCs and their applications. This will further expand the market's growth rate in the future.
Restraint/Challenge
- Standardization and Quality Control
On the other hand, maintaining consistent quality and characteristics of MSCs across different batches is expected to obstruct market growth. Standardization and quality control measures are necessary to ensure the reliability and reproducibility of results in research and clinical applications. Moreover, high cost of treatment and lack of therapeutic advancement related to vitro properties of stem cells is expected to become the biggest and foremost challenge for the growth of the market in the forecast period of 2023-2030.
This global mesenchymal stem cells market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global mesenchymal stem cells market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- 2021 年 7 月，Minovia Therapeutics, Ltd. 与 Astellas Pharma, Inc. 达成全球许可协议和战略合作，旨在开发用于治疗线粒体功能障碍所致疾病的尖端干细胞治疗方案。此次合作旨在加速同种异体线粒体细胞治疗计划的开发。两家公司将合作利用 Astellas 的转基因诱导多能干细胞和 Minovia 的 MAT 平台技术研究潜在的细胞治疗方案前景
全球间充质干细胞市场范围
全球间充质干细胞市场根据类型、产品类型、分离来源、适应症、应用和最终用户进行细分。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
类型
- 自体
- 同种异体
产品类型
- 人类 MSC
- 小鼠MSC
- 大鼠 MSC
孤立之源
- 骨髓
- 脐带血
- 外周血
- 输卵管
- 胎儿肝脏
- 肺
- 脂肪组织
指征
- 骨和软骨修复
- 心血管疾病
- 炎症和免疫疾病
- 肝脏疾病
- 癌症
- 移植物抗宿主病 (GvHD)
- 其他的
应用
- 疾病模型
- 药物开发与发现
- 干细胞储存
- 组织工程
- 毒理学研究
- 其他的
最终用户
- 诊所
- 医院
- 其他的
全球间充质干细胞市场分析/洞察
对全球间充质干细胞市场进行了分析，并按国家、类型、产品类型、分离来源、适应症、应用和最终用户提供了市场规模洞察和趋势。
全球间充质干细胞市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。
由于主要关键参与者的存在、研发支出的增加、先进研究设施的可用性、政府举措的不断增加以及该地区健康意识的不断提高，北美在全球间充质干细胞市场中占据主导地位。
由于研发活动的增加、医疗保健基础设施的投资增加以及政府支持的增加，预计亚太地区在 2023 年至 2030 年的预测期内将以最高的增长率增长。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和全球间充质干细胞市场份额分析
全球间充质干细胞市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球间充质干细胞市场的关注有关。
全球间充质干细胞市场的一些主要参与者包括：
- 龙沙（瑞士）
- 赛默飞世尔科技公司（美国）
- Bio-Techne (美国)
- ATCC（美国典型培养物保藏中心（美国）
- 默克集团（德国）
- PromoCell GmbH (德国)
- Genlantis, Inc.（美国）
- Celprogen Inc.（美国）
- Cell Applications, Inc.（美国）
- Cyagen Biosciences（美国）
- Axol Bioscience Ltd.（英国）
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
